Physician profile
Ronald Keith Risinger
NPI 1376760819
$182,911.41
in general payments reported to CMS, 2019-2025
9 companies · $83K in 2025
The $83K reported for 2025 was more than what 99% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $47.39 · 2021: $93.65 · 2022: $9,603 · 2023: $40K · 2024: $50K · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $119K · Travel and Lodging: $53K · Food and Beverage: $1,084 · Gift: $300 · Entertainment: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $118,850.00 |
| Travel and Lodging | $52,515.87 |
| Food and Beverage | $1,083.55 |
| Gift | $300.49 |
| Entertainment | $154.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Organizers, INC. | $181,298.48 | 2019-2025 | Carriere Slx 3d, Ortho Organizers, Carriere |
| Align Technology, INC. | $395.17 | 2019-2023 | Invisalign Touch Up, Itero Element 5d Plus Lite, Invisalign First - Comprehensive |
| Ultradent Products INC | $304.84 | 2023-2024 | Opalescence |
| Henry Schein, INC. | $269.20 | 2022 | |
| 3m Company | $243.88 | 2019-2022 | |
| Envista Holdings Corporation | $227.31 | 2024-2025 | Spark, Damon, Advance Sync |
| Ormco Corporation | $114.91 | 2021-2023 | Damon |
| Lightforce Orthodontics, INC. | $41.24 | 2023 | |
| Nobel Biocare USA | $16.38 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Risinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.